Immune correlates of vaccine protection against HIV-1 acquisition-Reference-Cited by-同舟云学术

Immune correlates of vaccine protection against HIV-1 acquisition

Published:2015-10-21 Issue:310 Volume:7 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Corey Lawrence¹,Gilbert Peter B.²,Tomaras Georgia D.³,Haynes Barton F.³,Pantaleo Giuseppe⁴,Fauci Anthony S.⁵

Affiliation:

1. HIV Vaccine Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

2. Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

3. Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.

4. Lausanne University Hospital and Swiss Vaccine Research Institute, Lausanne 1011, Switzerland.

5. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Abstract

Vaccine-induced non–broadly neutralizing antibodies are associated with protection against HIV-1 acquisition.

Funder

NIH

Bill and Melinda Gates Foundation

Duke Center for AIDS Research Immunology Core

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference59 articles.

1. High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa

2. Ten years after Dublin: principal trends in HIV surveillance in the EU/EEA, 2004 to 2013

3. Today’s HIV/AIDS Epidemic (Centers for Disease Control and Prevention Atlanta GA 2014).

4. The Gap Report (Joint United Nations Programme on HIV/AIDS Geneva 2014).

5. HIV Vaccine Development — Improving on Natural Immunity

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Idiotopes of antibodies against HIV‐1 CD4‐induced epitope shared with those against microorganisms;Immunology;2023-12-16

2. Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein;Frontiers in Immunology;2023-11-17

3. Estimating counterfactual placebo HIV incidence in HIV prevention trials without placebo arms based on markers of HIV exposure;Clinical Trials;2023-10-25

4. Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation;Journal of Virology;2023-09-28

5. Carbohydrate‐Based Antiviral Vaccines;Carbohydrate‐Based Therapeutics;2023-09-05